Bull Stock Aba Chemicals Corporation(300261) , whose share price has quadrupled in three months, will resume trading on the first trading day after the Spring Festival.
The company again conducted a number of risk tips, pointing out that the increase of share price was significantly higher than the change degree of the company's fundamentals. In addition, the company also pointed out again that the company has no business contact and cooperation with Pfizer and has not signed a cooperation agreement with Pfizer.
4x Bull Stock Aba Chemicals Corporation(300261) resume trading tomorrow
Daniel stock Aba Chemicals Corporation(300261) (300261. SZ) released the announcement of the company's stock suspension verification results and resumption of trading on February 6.
The above announcement mentioned that the trading of the company's shares will resume from the opening of the market on Monday, February 7, 2022.
At the same time, Aba Chemicals Corporation(300261) also carried out a number of risk tips.
Aba Chemicals Corporation(300261) said that "carbonic anhydride and its derivatives can be used to synthesize Pfizer covid-19 oral drug parovid from the process flow" stated in the reply to the concern letter disclosed by the company on January 5, 2022, in which carbonic anhydride and its derivatives refer to compounds rather than products produced by the company, It cannot be determined that the carbonic anhydride and its derivatives produced by the company can be used to synthesize Pfizer covid-19 oral drug. The company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, has not supplied Carlin anhydride products to Pfizer, Pfizer has not provided the company with any quality standards for the procurement of covid-19 oral drug front-end raw materials, and the company's customers refuse to provide the end use of Carlin anhydride and its derivatives, The company is unable to determine whether the produced carbonic anhydride products meet the needs of Pfizer products, and has not conducted relevant technical verification. It is unable to determine whether the carbonic anhydride products produced by the company are or can become Pfizer covid-19 oral drug intermediates.
Aba Chemicals Corporation(300261) also said that as of December 31, 2021, the company's sales revenue of carbonic anhydride and its derivatives in 2021 was 27.073 million yuan (excluding tax), accounting for about 1% - 2% of the company's total operating revenue in 2021, which is relatively small, and is not expected to have a significant impact on the company's performance in 2021. As of December 31, 2021, the total amount of orders on hand for carbonic anhydride and its derivatives was 63.5408 million yuan (excluding tax).
Aba Chemicals Corporation(300261) also said that from November 1, 2021 to January 28, 2022, the cumulative increase of the company's stock price was about 432.55%, which was significantly higher than the change degree of the company's fundamentals and did not match the company's current fundamentals. Since November 1, 2021, the rising range of the company's stock price and the level of dynamic P / E ratio have been significantly higher than the industry average.
According to the annual performance forecast previously released by Aba Chemicals Corporation(300261) , the company's expected performance growth in 2021 is not high. According to the above performance forecast, Aba Chemicals Corporation(300261) it is estimated that the net profit attributable to the shareholders of the listed company in 2021 will be 180-200 million yuan, an increase of 11.79% - 24.21% over the same period of the previous year, and the net profit after deducting non recurring profits and losses will be 142-162 million yuan, an increase of - 1.54% - 12.33% over the same period of the previous year. The company's non recurring profit and loss in 2021 was about 38 million yuan, mainly from changes in fair value.
In fact, Aba Chemicals Corporation(300261) has been suspended once since December 29, 2021 due to serious abnormal fluctuations in stock trading, and resumed trading since the opening of the market on January 6, 2022 (Thursday). On the day of resumption, the stock of Aba Chemicals Corporation(300261) fell by 1.83% and fell sharply by 19.99% the next day, but it soon regained its upward trend.
In the reply to the letter of concern of Shenzhen Stock Exchange on January 5, 2022, Aba Chemicals Corporation(300261) responded to the fact that Wang Xinya, one of the actual controllers of the company, reduced 19 million shares of the company through block trading on November 30, 2021. According to Aba Chemicals Corporation(300261) , Wang Xinya is one of the founding shareholders and actual controllers of the company. His shares of the company were obtained before the initial listing. Since the company was listed on the gem of Shenzhen Stock Exchange on September 6, 2011, Wang Xinya only reduced 2 million shares of the company in May 2015. On November 30, 2021, Wang Xinya reduced 19 million shares of the company through block trading. The main reason for this reduction is personal capital needs such as loan repayment and foreign investment.
Statistics show that Aba Chemicals Corporation(300261) has frequently been on the dragon and tiger list in the past three months, mostly with the participation of business department seats, but institutional seats have also appeared frequently.
several stocks in the A-share market have doubled in recent months
part of the increase was amazing
In fact, in recent months, although the performance of the main indexes in the A-share market is weak, the performance of individual stocks is quite active. In addition to Aba Chemicals Corporation(300261) , there are many stocks whose share prices have doubled or even doubled several times.
Statistics show that nearly 20 stocks in Shanghai and Shenzhen have doubled since November 2021, and many stocks have even increased by more than 200%. Among them, Andon Health Co.Ltd(002432) increased by more than 900%, Aba Chemicals Corporation(300261) increased by more than 400%, Xinxiang Tuoxin Pharmaceutical Co.Ltd(301089) increased by more than 300%.
From the perspective of the maximum increase from the lowest price in the above range, the increase is even more amazing, of which Andon Health Co.Ltd(002432) has increased by more than 14 times.
